Topical Calcipotriol: A Ray of Hope for Clear Cell Acanthoma?
"Could this Vitamin D-based treatment offer a non-surgical solution for a rare skin condition?"
Clear cell acanthoma (CCA), while not frequently diagnosed, has always piqued the interest of dermatologists. This benign skin growth often goes unnoticed until a biopsy because its appearance can vary so much.
Thankfully, dermoscopy, a skin examination technique using magnification, has significantly improved how accurately doctors can identify typical CCA. Features like pinpoint blood vessel patterns and a scaly ring around the edge of the growth are now easier to spot.
Traditionally, treatment for CCA involves removing or destroying the growth through surgery or cryotherapy (freezing). However, a recent study explores a different approach: topical calcipotriol, a cream applied directly to the skin. The results suggest it could completely eliminate CCA within a couple of months, with no return a year later. This opens up an exciting possibility for a less invasive treatment option.
A Conservative Treatment Option
A 2014 report proposed topical calcipotriol as a conservative treatment for clear cell acanthoma. The report described complete regression after 2 months, with no relapse 1 year after treatment ended. Dermoscopy monitored changes throughout treatment and was useful for both diagnosis and therapeutic follow-up. The findings were also described as supporting an inflammatory etiology for clear cell acanthoma.
Calcipotriol: A Non-Invasive Treatment Option for Clear Cell Acanthoma?
A 78-year-old man presented with a solitary, palpable, erythematous, dome-shaped, 8-mm papule on his left leg, which had been present for a few months. The lesion was asymptomatic. The patient had no personal or family history of psoriasis. Dermoscopy revealed dotted vessels organized as “strings of pearls” and keratinized collarette, which are indicative patterns of CCA. Given these clear signs and the patient's history, psoriasis was reasonably ruled out.
- After 15 days of therapy: A yellowish, irregular, star-shaped area appeared in the center.
- After 30 days of therapy: A scaly collarette emerged, with a few dotted vessels remaining and the central yellowish area becoming more prominent.
- After 45 days of therapy: The lesion was no longer palpable, replaced by a pink to light brown area lacking vascular structures but covered with fine white scales. A few small, brown-red crusts/microerosions were noted.
- After 60 days of therapy: Only a light brown pigmentation remained on a slightly pinkish background, with no visible vessels, leading to treatment interruption.
- Twelve months after stopping therapy: No recurrence appeared, with only a slightly hypochromic area visible both dermoscopically and clinically.
Promising Early Evidence
Available reports describe topical calcipotriol as a vitamin D-based cream and a potential non-invasive alternative to surgery for clear cell acanthoma. One report documented complete regression after 2 months and no relapse 1 year after treatment ended. Dermoscopy was used to monitor the lesion during treatment, supporting its role in therapeutic follow-up as well as diagnosis. These findings present calcipotriol as promising, although the evidence described is based on a reported treatment experience rather than broad clinical evidence.
An Unresolved Cause
DermNet NZ states that it is currently not known why clear cell acanthoma occurs. This unresolved cause limits how confidently the disease process can be connected to any particular treatment mechanism. The available source does not report treatment failure or a specific adverse outcome for calcipotriol. It instead highlights an important uncertainty surrounding the condition itself.
Non-Invasive Compared With Ablative Care
Topical calcipotriol is described as a non-invasive alternative to traditional clear cell acanthoma treatments. The comparison identifies surgery, cryotherapy, and electrocoagulation as ablative methods. According to the source, these traditional approaches can carry risks. The proposed distinction is therefore between a topical cream and procedures that remove or destroy tissue.
Looking Ahead: A Promising Alternative?
This case presents a promising alternative for treating clear cell acanthoma, particularly for patients who may not be suitable candidates for surgery or cryotherapy. While further studies with larger groups are needed to confirm these findings, the rapid and progressive improvement observed with topical calcipotriol suggests it acts effectively against CCA. This could pave the way for a less invasive and more patient-friendly approach to managing this skin condition.
The Need for Conservative Options
A 2014 report proposed topical calcipotriol as a conservative therapy for clear cell acanthoma. It reported complete regression after 2 months and no relapse 1 year after treatment ended. Dermoscopy monitored the lesion's changes and was useful for diagnosis and therapeutic follow-up. The report also suggested that the response supported an inflammatory nature for clear cell acanthoma.
Hope From a Reported Case
A case report on clear cell acanthoma with an atypical location cites a published case that regressed after 2 months of calcipotriol treatment. The authors say this response suggests an inflammatory nature for clear cell acanthoma. This experience offers a potential treatment perspective for patients, but it represents a reported case rather than evidence of universal effectiveness. The source does not provide broader outcome statistics.